Raymond James & Associates Inogen Inc Transaction History

Raymond James & Associates

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$63.19 - $95.15 $139,144 - $209,520	-2,202 Closed	0 $0
Q1 2019 May 06, 2019	BUY	$90.12 - $152.23 $22,079 - $37,296	245 Added 12.52%	2,202 $210,000
Q4 2018 Feb 11, 2019	SELL	$112.83 - $239.74 $456,397 - $969,748	-4,045 Reduced 67.39%	1,957 $243,000
Q3 2018 Nov 14, 2018	BUY	$189.1 - $282.92 $469,535 - $702,490	2,483 Added 70.56%	6,002 $1.47 Million
Q2 2018 Aug 14, 2018	BUY	$123.8 - $192.48 $139,770 - $217,309	1,129 Added 47.24%	3,519 $656,000
Q1 2018 May 14, 2018	BUY	$114.22 - $133.22 $38,492 - $44,895	337 Added 16.42%	2,390 $294,000
Q4 2017 Feb 14, 2018	BUY	$93.4 - $128.74 $191,750 - $264,303	2,053	2,053 $244,000

143

21M

119K

149K

Ticker INGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 22,866,500
Market Cap $214M
Description
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.